35 related articles for article (PubMed ID: 6490189)
1. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I
Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586
[TBL] [Abstract][Full Text] [Related]
2. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
3. The removal of uremic small and middle molecules and free amino acids by carbon hemoperfusion.
Oulès R; Asaba H; Neuhäuser M; Yahiel V; Gunnarsson B; Bergström J; Fürst P
Trans Am Soc Artif Intern Organs; 1977; 23():583-90. PubMed ID: 910385
[No Abstract] [Full Text] [Related]
4. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
5. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
[TBL] [Abstract][Full Text] [Related]
6. Active carbon and its controversial ability to adsorb uremic toxins.
Giordano C; Esposito R; Cirillo D; Betuel H; Fredel A; Pluvio M; Mazzola G; Longhi R; Manzo M
Int J Artif Organs; 1984 Jul; 7(4):177-80. PubMed ID: 6490189
[No Abstract] [Full Text] [Related]
7. History of sorbents in uremia.
Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW
Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746
[No Abstract] [Full Text] [Related]
8. Adequacy of hemoperfusion for blood purification in uremia.
Chang TM
Contrib Nephrol; 1993; 103():10-25. PubMed ID: 8354053
[No Abstract] [Full Text] [Related]
9. Hemoperfusion results in uremia.
Gelfand MC; Winchester JF
Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
[No Abstract] [Full Text] [Related]
10. Rationale for combined hemoperfusion/hemodialysis in uremia.
Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
[No Abstract] [Full Text] [Related]
11. Adsorbent hemoperfusion: nonbiological particulate matter.
Van Wagenen R; Coleman DL; Andrade JD
Kidney Int Suppl; 1975 Feb; (3):397-400. PubMed ID: 1099318
[No Abstract] [Full Text] [Related]
12. Sorbent augmented dialysis: minor addition or major advance in therapy?
Winchester JF; Ronco C; Brady JA; Golds E; Clemmer J; Cowgill LD; Muller TE; Levin NW
Blood Purif; 2001; 19(2):255-9. PubMed ID: 11150820
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
